Clinical Trial Update: Metformin and Sitagliptin Therapy for Adult Patients With Type 2 Diabetes Admitted to the General Medical Unit [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating metformin and sitagliptin in adults with type 2 diabetes has been withdrawn. No results reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• metformin and sitagliptin therapy

Snippet

Sponsor: Rush University Medical Center | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: WITHDRAWN